Board of Directors

Jeffry Weinhuff

Executive Chairman and Managing Partner, Visionary Venture Fund

Jeffry Weinhuff is a managing partner of Visionary Venture Fund, a late-stage venture capital fund exclusively focused on investing in the most promising ophthalmology companies. Mr. Weinhuff has been active in the private equity realm for over 30 years. At Jefferies & Co., a premier mid-market investment bank, he founded the investment banking and capital markets groups, served as the head of investment banking and the commitment committee, and was a member of the board of directors. Prior to Jefferies, Mr. Weinhuff was a partner at Drexel Burnham Lambert, where he founded and co-headed the buyer advisory group and served on the underwriting committee.

Mr. Weinhuff holds an MBA from the Marshall School of Business at the University of Southern California and a BS in economics from the University of California, Santa Barbara.

Chief Executive Officer

Elad Kedar is a seasoned CEO with over 20 years of executive experience in the pharmaceutical industry, developing, scaling, and commercializing healthcare organizations. He has proven success in various executive leadership positions (such as CFO Lilly South-East Europe, Founder of Pharma Swiss in Israel, CEO of Orasis Pharmaceuticals since inception) across different geographies and diverse expertise in all stages of the pharmaceutical life cycle, from early-stage clinical development to commercialization.

Mr. Kedar holds an MBA from INSEAD and a B.A. in accounting and law from Tel Aviv University.

Luzi Andreas
Senior Global Pharmaceutical Executive

Luzi von Bidder is an experienced industry executive who served for over 17 years as chairman and chief executive officer of Novartis Ophthalmics AG and as a member of the Novartis pharma executive committee. Currently he is on the board of directors of several private healthcare companies. Most recently, Mr. von Bidder was chairman of the Swiss listed company Acino Holding AG. Mr. von Bidder is the founder of four healthcare startups and has extensive experience in the M&A field.

Mr. von Bidder holds an MBA and a BA in economics from University of St. Gallen.

Yoav Shaked
Partner, Sequoia Capital

Yoav Shaked is a business leader with over 15 years of executive and entrepreneurial experience in the healthcare and medical device industry. Prior to Sequoia, he co-founded MedPoint Technologies Ltd., and founded YMed, which was later acquired by C.R. Bard.

Mr. Shaked currently serves as a board member at the following companies: Endospan, Polytech GmbH, Vibrant Gastro, and Dario Health.

Mr. Shaked holds a BA in biology from the Hebrew University of Jerusalem.

David Ben Ami
General Partner, SBI
David Ben Ami brings over 30 years of experience in the health sector. His activities span from management to business development, corporate strategy, and entrepreneurship in the life sciences industry. Mr. Ben Ami was the founder and executive chairman of NASDAQ-listed company Macrocure Ltd. from 2008 to 2016. Prior to that, he was the CEO of NVR Labs Ltd. from 2005 to 2010. Earlier in his rich career, Mr. Ben Ami was the Israeli country director for Boston Scientific from 2003 to 2005, and the director of business development for Teva Israel and Teva Medical from 1990 through 2002. Mr. Ben Ami received his MBA and BA in Economics & Management from Tel Aviv University
Partner and VP, Bluestem Capital
During his twenty-year tenure at Bluestem, Mr. Stowater has been responsible for portfolio management, serving on boards of dozens of companies.  Prior to joining Bluestem, he was an assistant vice president at Citibank South Dakota.  Earlier in his career, he spent 11 years with the State of South Dakota’s Bureau of Finance and Management. Mr. Stowater holds BS in agriculture economics and MS in economics from South Dakota State University